Atrial Fibrillation With and Without Cardiovascular Risk Factors and Stroke Mortality.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Mar 2021
Historique:
pubmed: 20 6 2020
medline: 16 11 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

The association between atrial fibrillation (AF) and risk of stroke mortality among men and women without traditional cerebrocardiovascular risk factors (TCVRFs) is unclear. This study aimed to determine whether AF was a risk factor for stroke and total cardiovascular disease mortality among individuals without TCVRFs. A total of 90,629 Japanese subjects from the Ibaraki Prefectural Health Study aged 40-79 years, with and without TCVRFs, were studied from 1993 to 2013. Hazard ratios (HRs) were calculated using the Cox proportional hazard regression model stratified by sex and the presence of TCVRFs. Covariates were age, systolic blood pressure, anti-hypertensive medication use, and serum total cholesterol levels. A standard 12-lead electrocardiogram at rest was used to screen AF. Cause-specific mortality was classified according to the International Classification of Disease code. Compared with participants without AF, multivariable-adjusted hazard ratios (with 95% confidence intervals) for stroke mortality among participants without TCVRFs were 4.3 (1.1-17.8) and 15.0 (5.5-40.8) for men and women with AF, respectively. HRs for total cardiovascular disease mortality were 6.2 (2.8-14.2) for men and 10.7 (4.8-24.1) for women. For participants with TCVRFs, multivariable-adjusted HRs for stroke mortality were 3.1 (2.2-4.6) and 4.3 (2.6-7.3), whereas HRs for total cardiovascular disease mortality were 2.9 (2.2-3.8) and 3.5 (2.4-5.1) for men and women, respectively. AF was found to be an independent risk factor for stroke and total cardiovascular mortality even in individuals without other TCVRFs.

Identifiants

pubmed: 32554949
doi: 10.5551/jat.53629
pmc: PMC8048946
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-248

Références

Int J Cardiol. 2013 Sep 1;167(5):1807-24
pubmed: 23380698
Circulation. 2011 Dec 6;124(23):2502-11
pubmed: 22064594
JAMA. 2011 May 25;305(20):2080-7
pubmed: 21610240
Int J Epidemiol. 1999 Dec;28(6):1059-65
pubmed: 10661648
J Atheroscler Thromb. 2019 Jul 1;26(7):670-677
pubmed: 31231081
J Stroke. 2016 May;18(2):129-37
pubmed: 27283277
J Epidemiol. 2017 Aug;27(8):360-367
pubmed: 28390793
Am J Med. 2002 Oct 1;113(5):359-64
pubmed: 12401529
Lancet. 1987 Mar 7;1(8532):526-9
pubmed: 2881082
BMJ. 2016 Jan 19;532:h7013
pubmed: 26786546
Int J Cardiol. 2010 Mar 4;139(2):173-80
pubmed: 19046608
J Epidemiol. 2005 Sep;15(5):194-6
pubmed: 16195640
Am J Med. 1995 May;98(5):476-84
pubmed: 7733127
Int J Cardiol. 2015 Apr 1;184:692-698
pubmed: 25771238
Stroke. 2016 Mar;47(3):895-900
pubmed: 26786114
Int J Cardiol. 2014 Jan 1;170(3):413-8
pubmed: 24321327
N Engl J Med. 1982 Apr 29;306(17):1018-22
pubmed: 7062992
Br Heart J. 1954 Apr;16(2):189-94
pubmed: 13160271
Circ J. 2007 Jun;71(6):814-9
pubmed: 17526974
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Nihon Koshu Eisei Zasshi. 1991 Dec;38(12):901-9
pubmed: 1816882
BMJ. 2018 Apr 26;361:k1453
pubmed: 29699974
Neurology. 1978 Oct;28(10):973-7
pubmed: 570666
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669
Stroke. 2000 Nov;31(11):2616-22
pubmed: 11062284

Auteurs

Toshimi Sairenchi (T)

Department of Public Health, Dokkyo Medical University School of Medicine.
Ibaraki Health Plaza.
Ibaraki Health Service Association.

Kazumasa Yamagishi (K)

Ibaraki Health Plaza.
Ibaraki Health Service Association.
Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.

Hiroyasu Iso (H)

Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.

Fujiko Irie (F)

Department of Health and Welfare, Ibaraki Prefectural Office.

Ai Koba (A)

Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba.
Department of Health and Welfare, Ibaraki Prefectural Office.

Masanori Nagao (M)

Ibaraki Health Plaza.
Office of Epidemiology, Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University.

Mitsumasa Umesawa (M)

Department of Public Health, Dokkyo Medical University School of Medicine.
Ibaraki Health Plaza.

Yasuo Haruyama (Y)

Department of Public Health, Dokkyo Medical University School of Medicine.

Nobuko Takaoka (N)

Department of Public Health, Dokkyo Medical University School of Medicine.
Ibaraki Health Plaza.

Hiroshi Watanabe (H)

Ibaraki Health Service Association.

Gen Kobashi (G)

Department of Public Health, Dokkyo Medical University School of Medicine.

Hitoshi Ota (H)

Ibaraki Health Plaza.
Ibaraki Health Service Association.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH